Association of genetic variation in mitotic kinases with breast cancer risk

Xianshu Wang, Zachary S. Fredericksen, Robert A. Vierkant, Matthew L. Kosel, V. Shane Pankratz, James R Cerhan, Christina Justenhoven, Hiltrud Brauch, Janet E Olson, Fergus J Couch

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

An RNAi-based functional screening of mitotic kinases in Drosophila recently identified a number of members of the kinome that are required for normal cell division. Depletion of these kinases resulted in a number of different mitotic abnormalities including spindle malformation, chromosome mis-segregation, centrosome amplification and failure of cytokinesis (Bettencourt-Dias et al. in Nature 432:980-987, 2004). Since mitotic defects are commonly observed in cancer cells, these kinases may contribute to tumor development and/or progression. To investigate whether common genetic variation in the mitotic kinases are associated with breast cancer risk, we genotyped 386 single nucleotide polymorphisms (SNPs) from 44 mitotic kinase genes, in 798 breast cancer cases and 843 unaffected controls from a clinic-based study. A total of 22 SNPs from 13 kinase genes displayed significant associations with breast cancer risk (P trend ≤ 0.05), including two SNPs from FYN (rs6914091 and rs1465061) that remained of interest after accounting for multiple testing (q = 0.06). These associations were stronger when evaluating cases with estrogen and progesterone receptor positive tumors. In addition, haplotype-based tests identified significant associations with risk for common haplotypes of the MAST2 (P = 0.04) and MAP2K4 (P = 0.006) genes. Although requiring replication, these findings suggest that genetic polymorphisms in mitotic kinases that have been implicated in chromosome instability and aneuploidy may contribute to the development of breast cancer.

Original languageEnglish (US)
Pages (from-to)453-462
Number of pages10
JournalBreast Cancer Research and Treatment
Volume119
Issue number2
DOIs
StatePublished - Jan 2010

Fingerprint

Phosphotransferases
Breast Neoplasms
Single Nucleotide Polymorphism
Haplotypes
Genes
Neoplasms
Centrosome
Chromosomal Instability
Chromosome Segregation
Cytokinesis
Aneuploidy
Genetic Polymorphisms
Progesterone Receptors
RNA Interference
Estrogen Receptors
Cell Division
Drosophila

Keywords

  • Breast cancer risk
  • Haplotype
  • Mitosis
  • Mitotic kinase
  • Single nucleotide polymorphism (SNP)

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Association of genetic variation in mitotic kinases with breast cancer risk. / Wang, Xianshu; Fredericksen, Zachary S.; Vierkant, Robert A.; Kosel, Matthew L.; Pankratz, V. Shane; Cerhan, James R; Justenhoven, Christina; Brauch, Hiltrud; Olson, Janet E; Couch, Fergus J.

In: Breast Cancer Research and Treatment, Vol. 119, No. 2, 01.2010, p. 453-462.

Research output: Contribution to journalArticle

Wang, X, Fredericksen, ZS, Vierkant, RA, Kosel, ML, Pankratz, VS, Cerhan, JR, Justenhoven, C, Brauch, H, Olson, JE & Couch, FJ 2010, 'Association of genetic variation in mitotic kinases with breast cancer risk', Breast Cancer Research and Treatment, vol. 119, no. 2, pp. 453-462. https://doi.org/10.1007/s10549-009-0404-3
Wang, Xianshu ; Fredericksen, Zachary S. ; Vierkant, Robert A. ; Kosel, Matthew L. ; Pankratz, V. Shane ; Cerhan, James R ; Justenhoven, Christina ; Brauch, Hiltrud ; Olson, Janet E ; Couch, Fergus J. / Association of genetic variation in mitotic kinases with breast cancer risk. In: Breast Cancer Research and Treatment. 2010 ; Vol. 119, No. 2. pp. 453-462.
@article{bef94b31980c4b80a7acf2dc15839fe9,
title = "Association of genetic variation in mitotic kinases with breast cancer risk",
abstract = "An RNAi-based functional screening of mitotic kinases in Drosophila recently identified a number of members of the kinome that are required for normal cell division. Depletion of these kinases resulted in a number of different mitotic abnormalities including spindle malformation, chromosome mis-segregation, centrosome amplification and failure of cytokinesis (Bettencourt-Dias et al. in Nature 432:980-987, 2004). Since mitotic defects are commonly observed in cancer cells, these kinases may contribute to tumor development and/or progression. To investigate whether common genetic variation in the mitotic kinases are associated with breast cancer risk, we genotyped 386 single nucleotide polymorphisms (SNPs) from 44 mitotic kinase genes, in 798 breast cancer cases and 843 unaffected controls from a clinic-based study. A total of 22 SNPs from 13 kinase genes displayed significant associations with breast cancer risk (P trend ≤ 0.05), including two SNPs from FYN (rs6914091 and rs1465061) that remained of interest after accounting for multiple testing (q = 0.06). These associations were stronger when evaluating cases with estrogen and progesterone receptor positive tumors. In addition, haplotype-based tests identified significant associations with risk for common haplotypes of the MAST2 (P = 0.04) and MAP2K4 (P = 0.006) genes. Although requiring replication, these findings suggest that genetic polymorphisms in mitotic kinases that have been implicated in chromosome instability and aneuploidy may contribute to the development of breast cancer.",
keywords = "Breast cancer risk, Haplotype, Mitosis, Mitotic kinase, Single nucleotide polymorphism (SNP)",
author = "Xianshu Wang and Fredericksen, {Zachary S.} and Vierkant, {Robert A.} and Kosel, {Matthew L.} and Pankratz, {V. Shane} and Cerhan, {James R} and Christina Justenhoven and Hiltrud Brauch and Olson, {Janet E} and Couch, {Fergus J}",
year = "2010",
month = "1",
doi = "10.1007/s10549-009-0404-3",
language = "English (US)",
volume = "119",
pages = "453--462",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Association of genetic variation in mitotic kinases with breast cancer risk

AU - Wang, Xianshu

AU - Fredericksen, Zachary S.

AU - Vierkant, Robert A.

AU - Kosel, Matthew L.

AU - Pankratz, V. Shane

AU - Cerhan, James R

AU - Justenhoven, Christina

AU - Brauch, Hiltrud

AU - Olson, Janet E

AU - Couch, Fergus J

PY - 2010/1

Y1 - 2010/1

N2 - An RNAi-based functional screening of mitotic kinases in Drosophila recently identified a number of members of the kinome that are required for normal cell division. Depletion of these kinases resulted in a number of different mitotic abnormalities including spindle malformation, chromosome mis-segregation, centrosome amplification and failure of cytokinesis (Bettencourt-Dias et al. in Nature 432:980-987, 2004). Since mitotic defects are commonly observed in cancer cells, these kinases may contribute to tumor development and/or progression. To investigate whether common genetic variation in the mitotic kinases are associated with breast cancer risk, we genotyped 386 single nucleotide polymorphisms (SNPs) from 44 mitotic kinase genes, in 798 breast cancer cases and 843 unaffected controls from a clinic-based study. A total of 22 SNPs from 13 kinase genes displayed significant associations with breast cancer risk (P trend ≤ 0.05), including two SNPs from FYN (rs6914091 and rs1465061) that remained of interest after accounting for multiple testing (q = 0.06). These associations were stronger when evaluating cases with estrogen and progesterone receptor positive tumors. In addition, haplotype-based tests identified significant associations with risk for common haplotypes of the MAST2 (P = 0.04) and MAP2K4 (P = 0.006) genes. Although requiring replication, these findings suggest that genetic polymorphisms in mitotic kinases that have been implicated in chromosome instability and aneuploidy may contribute to the development of breast cancer.

AB - An RNAi-based functional screening of mitotic kinases in Drosophila recently identified a number of members of the kinome that are required for normal cell division. Depletion of these kinases resulted in a number of different mitotic abnormalities including spindle malformation, chromosome mis-segregation, centrosome amplification and failure of cytokinesis (Bettencourt-Dias et al. in Nature 432:980-987, 2004). Since mitotic defects are commonly observed in cancer cells, these kinases may contribute to tumor development and/or progression. To investigate whether common genetic variation in the mitotic kinases are associated with breast cancer risk, we genotyped 386 single nucleotide polymorphisms (SNPs) from 44 mitotic kinase genes, in 798 breast cancer cases and 843 unaffected controls from a clinic-based study. A total of 22 SNPs from 13 kinase genes displayed significant associations with breast cancer risk (P trend ≤ 0.05), including two SNPs from FYN (rs6914091 and rs1465061) that remained of interest after accounting for multiple testing (q = 0.06). These associations were stronger when evaluating cases with estrogen and progesterone receptor positive tumors. In addition, haplotype-based tests identified significant associations with risk for common haplotypes of the MAST2 (P = 0.04) and MAP2K4 (P = 0.006) genes. Although requiring replication, these findings suggest that genetic polymorphisms in mitotic kinases that have been implicated in chromosome instability and aneuploidy may contribute to the development of breast cancer.

KW - Breast cancer risk

KW - Haplotype

KW - Mitosis

KW - Mitotic kinase

KW - Single nucleotide polymorphism (SNP)

UR - http://www.scopus.com/inward/record.url?scp=74849114007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74849114007&partnerID=8YFLogxK

U2 - 10.1007/s10549-009-0404-3

DO - 10.1007/s10549-009-0404-3

M3 - Article

C2 - 19404734

AN - SCOPUS:74849114007

VL - 119

SP - 453

EP - 462

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 2

ER -